Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBioCardia Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.17 | -$0.17 | -$0.17 |
| Q2 2026 | 1 | -$0.17 | -$0.17 | -$0.17 |
| Q3 2026 | 1 | -$0.15 | -$0.15 | -$0.15 |
| Q4 2026 | 1 | -$0.15 | -$0.15 | -$0.15 |
BioCardia Inc. Earnings Date And Information
BioCardia Inc. last posted its earnings results on Tuesday, March 24th, 2026. The company reported $-0.06 earnings per share for the quarter, topping analysts' consensus estimates of $-0.2 by $0.14. The company had revenue of 0 for the quarter and had revenue of 0 for the year. BioCardia Inc. has generated $-1 earnings per share over the last year ($-1.23 diluted earnings per share) and currently has a price-to-earnings ratio of -1.4. BioCardia Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
BioCardia Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/24/2026 | Q4 2025 | -$0.20 | -$0.18 | 0.02 | $25.00 K | $0 |
| 11/12/2025 | Q3 2025 | -$0.25 | -$0.24 | 0.01 | $0 | $0 |
| 08/11/2025 | Q2 2025 | -$0.25 | -$0.40 | -0.15 | N/A | $0 |
| 05/14/2025 | Q1 2025 | -$0.39 | -$0.99 | -0.6 | N/A | $0 |
| 03/26/2025 | Q4 2024 | -$0.87 | -$0.84 | 0.03 | $22.50 K | $0 |
| 11/13/2024 | Q3 2024 | -$1.19 | -$0.61 | 0.58 | $200.00 K | $0 |
| 08/13/2024 | Q2 2024 | -$0.10 | -$0.88 | -0.78 | $50.00 K | $3.00 K |
| 05/14/2024 | Q1 2024 | -$3.00 | -$1.35 | 1.65 | N/A | $55.00 K |
| 03/27/2024 | Q4 2023 | -$1.65 | -$1.38 | 0.27 | N/A | $13.00 K |
| 11/08/2023 | Q3 2023 | -$1.80 | -$1.79 | 0.01 | N/A | $357.00 K |
| 08/09/2023 | Q2 2023 | -$2.25 | -$2.52 | -0.27 | N/A | $43.00 K |
| 05/10/2023 | Q1 2023 | -$1.95 | -$2.55 | -0.6 | N/A | $64.00 K |
| 03/29/2023 | Q4 2022 | -$2.70 | -$2.49 | 0.21 | N/A | $106.00 K |
| 11/09/2022 | Q3 2022 | -$3.45 | -$2.55 | 0.9 | N/A | $212.00 K |
| 08/10/2022 | Q2 2022 | -$4.20 | -$2.10 | 2.1 | N/A | $974.00 K |
| 05/11/2022 | Q1 2022 | -$2.25 | -$2.85 | -0.6 | N/A | $60.00 K |
| 03/29/2022 | Q4 2021 | -$3.15 | -$3.05 | 0.1 | N/A | $79.00 K |
| 11/10/2021 | Q3 2021 | -$0.21 | -$2.40 | -2.19 | N/A | $821.00 K |
| 08/12/2021 | Q2 2021 | -$3.15 | -$3.07 | 0.08 | N/A | $69.00 K |
| 05/13/2021 | Q1 2021 | -$3.15 | -$2.69 | 0.46 | N/A | $46.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
BioCardia Inc. Earnings: FAQ's
In the previous quarter, BioCardia Inc. (:BCDA) reported $-0.06 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.2 by $0.14.
The conference call for BioCardia Inc.'s latest earnings report can be listened to online.
The conference call transcript for BioCardia Inc.'s latest earnings report can be read online.
BioCardia Inc. (:BCDA) has a recorded net income of $-8,228,000.BioCardia Inc. has generated $-1.23 earnings per share over the last four quarters.
BioCardia Inc. (:BCDA) has a price-to-earnings ratio of -1.4 and price/earnings-to-growth ratio is -0.02.